Business Context and Reporting Period
Company: Nova Measuring Instruments Ltd. (NVMI)
Filing Type: Form 6-K (Press Release)
Reporting Period: Fourth Quarter and Full Year ended December 31, 2011
Filing Date: February 15, 2012
Business Overview: Provider of metrology solutions for the semiconductor process control market, focusing on stand-alone and integrated systems.
Key Financial Metrics
Fourth Quarter 2011
- Revenue: $19.2 million
- Gross Margin: 55%
- Operating Margin: 12%
- GAAP Net Income: $5.0 million ($0.18 per diluted share)
- Non-GAAP Net Income: $3.0 million ($0.11 per diluted share)
- Operating Cash Flow: $3.9 million
Full Year 2011
- Revenue: $102.8 million (Record high)
- Gross Margin: 56%
- Operating Margin: 24%
- GAAP Net Income: $28.1 million ($1.04 per diluted share)
- Non-GAAP Net Income: $27.1 million ($1.00 per diluted share)
- Operating Cash Flow: $25.1 million
- Total Cash Reserves: $87.1 million (Record high)
Material Changes vs. Prior Period
- Revenue Growth: Full-year revenue increased 19% year-over-year (from $86.6 million in 2010 to $102.8 million in 2011). However, Q4 revenue decreased 29% compared to Q4 2010 and 26% compared to Q3 2011.
- Profitability: Full-year GAAP net income increased to $28.1 million from $22.2 million in 2010. Q4 GAAP net income was $5.0 million, down from $7.5 million in Q4 2010.
- Unusual Item: Both Q4 and Full Year GAAP results include a $2.5 million non-cash benefit from the creation of a deferred income tax asset, resulting from a pattern of profitability.
- Expenses: Full-year operating expenses increased to $33.3 million from $25.6 million in 2010, driven by increased R&D and sales/marketing investments.
- Liquidity: Total cash reserves increased by $25.5 million year-over-year to $87.1 million.
Guidance, Outlook, and Risks
2012 First Quarter Guidance
- Revenue: $20.5 million to $23.0 million
- Operating Margin: 6% to 13%
- GAAP EPS: $0.04 to $0.09
- Non-GAAP EPS: $0.07 to $0.13
Management Commentary
Management described 2011 as the best year in company history, marking the first time revenues exceeded $100 million. Q4 revenues were at the high end of guidance due to favorable product mix and expense control. Backlog improved significantly in Q4, with bookings accelerating into early 2012. The company is seeing repeat orders for new products and is well-positioned in high-end technology nodes (28nm and below, including 11nm and 14nm).
Risks and Contingencies
- Dependency on two product lines and a small number of large customers and suppliers.
- Highly cyclical nature of the semiconductor industry.
- Dependency on OEM suppliers and a single manufacturing facility.
- Risks related to political and environmental instabilities in Asia and operations in Israel.
- Currency fluctuations and rapid technological changes.
Investor Verification Checklist
- Deferred Tax Asset: Verify the sustainability of the $2.5 million tax benefit included in GAAP earnings and its impact on future tax provisions.
- Q4 Revenue Decline: Investigate the 29% year-over-year revenue drop in Q4 despite full-year growth and improved backlog visibility.
- Non-GAAP Reconciliation: Review the reconciliation of GAAP to Non-GAAP measures to understand the exclusion of stock-based compensation and tax benefits.
- Cash Deployment: Assess the strategy for deploying the record $87.1 million cash reserve, given the lack of debt and significant investment in short-term interest-bearing deposits.
- Customer Concentration: Confirm the extent of dependency on a small number of large customers and the status of repeat orders in high-end nodes.